Aortic Diseases Clinical Trial
Official title:
Effect of DDD Pacing Titrated by Stepwise Changing of AVD on Aortic dP/dt
The maximum value of rate of left ventricular pressure increase, denoted by left ventricular
peak dP/dt value (dP/dt max), corresponds to the highest point on the curve of first
derivative of ventricular pressure curve with respect to time. It is one of the important
systolic performance parameters, which is primarily determined by ventricular contractility,
and emerges in isovolumetric contraction phase when aortic valves are closed. Thus it is not
influenced by parameters beyond ventricle such as aortic valve area, aortic elastance and
peripheral resistance. Despite these unique advantageous, the main reason for its limited
usage in assessing ventricular systolic performance instead of commonly used ejection
fraction is the difficulties in its calculation, which requires incessant intraventricular
pressure recordings.
The maximum value of acceleration rate of aortic pressure increase can be named as aortic
peak dP/dt. It, likewise, corresponds to the maximum value of first derivative of pressure
curve with respect to time.
Since it is one of the principal determining factors of aortic peak dP/dt, changing left
ventricular contractility thereby left ventricular peak dP/dt value is expected to change
aortic peak dP/dt in the same direction since all other variables being unchanged. Yet to
conclude the extent of this association and magnitude of change, measuring these parameters
for various contractility levels is necessary. In addition, impact of decreasing left
ventricular peak dP/dt by gradually lowering ventricular contractility upon aortic peak dP/dt
has not been investigated in previous studies.
In the present study, changes in left ventricular and aortic peak dP/dt values in response to
gradual reduction in LV contractility with stepwise changing (decremental shortening)
atrio-ventricular delay (AVD) by dual chamber pacing will be investigated in patients without
systolic dysfunction.
The maximum value of rate of left ventricular pressure increase, denoted by left ventricular
peak dP/dt value (dP/dt max), corresponds to the highest point on the curve of first
derivative of ventricular pressure curve with respect to time. It is one of the important
systolic performance parameters, which is primarily determined by ventricular contractility,
and emerges in isovolumetric contraction phase when aortic valves are closed. Thus it is not
influenced by parameters beyond ventricle such as aortic valve area, aortic elastance and
peripheral resistance. Despite these unique advantageous, the main reason for its limited
usage in assessing ventricular systolic performance instead of commonly used ejection
fraction is the difficulties in its calculation, which requires incessant intraventricular
pressure recordings.
The maximum value of acceleration rate of aortic pressure increase can be named as aortic
peak dP/dt. It, likewise, corresponds to the maximum value of first derivative of pressure
curve with respect to time. Unlike left ventricular peak dP/dt, it emerges after aortic valve
opens in early systolic ejection phase and thus is influenced by parameters beyond ventricle
in addition to left ventricular contractility such as aortic elastance and compliance,
vascular resistance, interference of forward and backward propagating pressure waves, stroke
volume and its ejection rate (dV/dt). Notably, aortic peak dP/dt can be expected to be one of
principal determinants in pressure-related damages in the vascular system. In structures
exposed to variable pressures, the extent of damage depends on the magnitude and rate of
acceleration of applied pressure in addition to susceptibility of the structures. Whether
this mechanism, which has numerous implications from the real world, operates in the organism
as well can be exemplified by the pulse pressure, which is an independent risk factor for
adverse cardiovascular events apart from systolic and diastolic blood pressure levels. A wide
pulse pressure suggests an accelerated rate of pressure increase. Therefore applications
lowering left ventricular and aortic peak dP/dt values may open a new therapeutic avenue in
management of pressure-related vascular damages such as aortic aneurisms. However, aortic
peak dP/dt concept is seldom found a place even in research articles.
Since it is one of the principal determining factors of aortic peak dP/dt, changing left
ventricular contractility thereby left ventricular peak dP/dt value is expected to change
aortic peak dP/dt in the same direction since all other variables being unchanged. Yet to
conclude the extent of this association and magnitude of change, measuring these parameters
for various contractility levels is necessary. In this context, it has been demonstrated that
narrowing of the QRS complex by cardiac resynchronization therapy (CRT) was shown to increase
left ventricular peak dP/dt value. This finding strongly suggests that widening of the QRS
complex, on the contrary, will decrease left ventricular peak dP/dt value. However, impact of
decreasing left ventricular peak dP/dt by gradually lowering ventricular contractility upon
aortic peak dP/dt has not been investigated in previous studies.
In the present study, changes in left ventricular and aortic peak dP/dt values in response to
gradual reduction in left ventricular (LV) contractility with stepwise changing (decremental
shortening) atrio-ventricular delay (AVD) by dual chamber pacing will be investigated in
patients without LV systolic dysfunction.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04149600 -
Identification of Genetic Causes of Calcific Aortic Valve Disease
|
||
Completed |
NCT02876263 -
Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta
|
N/A | |
Recruiting |
NCT03948555 -
Magnetic Resonance Imaging (MRI) for Aortic Dissection to Visualise Inflammation
|
||
Completed |
NCT02266342 -
GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry
|
||
Recruiting |
NCT05972018 -
Liposomal Bupivacaine/Bupivacaine in RS Blocks vs. Ropivacaine in RS Blocks And Catheters
|
Phase 4 | |
Completed |
NCT03727542 -
Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels
|
N/A | |
Not yet recruiting |
NCT06199401 -
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
|
N/A | |
Recruiting |
NCT06358248 -
Standardized Physician-modified Fenestrated Endograft Registry
|
||
Recruiting |
NCT05777681 -
Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts
|
||
Recruiting |
NCT04995640 -
CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair
|
||
Recruiting |
NCT05777460 -
Mid- and Long-term Outcomes of Custom-made Aortic Devices
|
||
Not yet recruiting |
NCT05554055 -
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
|
||
Unknown status |
NCT00851149 -
Pro-inflammatory Cytokines in Blood From Orthopedic Surgery Compared to Abdominal Aneurysm Repair
|
N/A | |
Recruiting |
NCT03824626 -
Biomechanical Reappraisal of Planning for Thoracic Endovascular Aortic Repair
|
||
Completed |
NCT02867501 -
Venous Distension in Patients With Aneurysmatic Arterial Disease
|
N/A | |
Completed |
NCT03617601 -
Metabolic Equivalent of Task (MET) in the Preoperative Assessment in Aortic Surgery
|
||
Completed |
NCT01775046 -
Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)
|
||
Completed |
NCT01526811 -
Endurantâ„¢ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
|
||
Completed |
NCT00538421 -
Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery
|
Phase 4 |